Kerala Ayurveda (BOM:530163) Forward Dividend Yield %: 0.00% (As of Jul. 04, 2026)


BOM:530163 Kerala Ayurveda Ltd BOM:530163
47 GF Score
Price ₹178.90
GF Value ₹318.84
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Kerala Ayurveda Forward Dividend Yield %?

Kerala Ayurveda BOM:530163 -0.69% 47 Forward Dividend Yield % is 0.00% as of Jul. 04, 2026. GuruFocus rates BOM:530163 with a GF Score™ of 47/100 and a GF Value™ of ₹318.84 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 506 Drug Manufacturers companies, Kerala Ayurveda ranks worse than 197628.26% on this metric.

As of today (2026-07-04), the Forward Annual Dividend Yield of Kerala Ayurveda is 0.00%.

As of today (2026-07-04), the Trailing Annual Dividend Yield of Kerala Ayurveda is 0.00%.

BOM:530163's Forward Dividend Yield % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.03
* Ranked among companies with meaningful Forward Dividend Yield % only.

Kerala Ayurveda's Dividends per Share for the three months ended in Mar. 2026 was ₹0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Kerala Ayurveda  (BOM:530163) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Kerala Ayurveda Forward Dividend Yield % Related Terms


BOM:530163 vs ZTS, UTHR: Forward Dividend Yield % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Kerala Ayurveda's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kerala Ayurveda Forward Dividend Yield % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kerala Ayurveda's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Kerala Ayurveda's Forward Dividend Yield % falls into.


BOM:530163
47GF Score
Kerala Ayurveda Ltd BOM:530163
Forward Dividend Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kerala Ayurveda Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

What does a Forward Dividend Yield % of 0.00% mean?
Kerala Ayurveda (BOM:530163) has a Forward Dividend Yield % of 0.00% as of Jul. 04, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Kerala Ayurveda and its competitors. According to the industry distribution chart, Kerala Ayurveda ranks #999999 out of 506 companies in the Drug Manufacturers industry.
Is Kerala Ayurveda's Forward Dividend Yield % too high?
Kerala Ayurveda's current Forward Dividend Yield % is 0.00%. Based on the distribution chart, Kerala Ayurveda ranks #999999 out of 506 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Kerala Ayurveda has a GF Score™ of 47/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Kerala Ayurveda's Forward Dividend Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Kerala Ayurveda ranks #999999 out of 506 companies for Forward Dividend Yield %. This places Kerala Ayurveda in the lower half of its industry. The industry median Forward Dividend Yield % is 2.03. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Drug Manufacturers company?
The median Forward Dividend Yield % among Drug Manufacturers companies is 2.03, based on 506 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Kerala Ayurveda and its competitors. For the Drug Manufacturers industry, the median Forward Dividend Yield % is 2.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kerala Ayurveda's current Forward Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kerala Ayurveda stock overvalued right now?
Based on GuruFocus' analysis, Kerala Ayurveda (BOM:530163) is currently considered Possible Value Trap. The stock's GF Value™ is ₹318.84, compared to a current price of ₹178.90 — trading 43.9% below its estimated fair value. The current Forward Dividend Yield % is 0.00%. Kerala Ayurveda's overall GF Score™ is 47/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Kerala Ayurveda (BOM:530163), the current Forward Dividend Yield % is 0.00% as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Kerala Ayurveda (BOM:530163) Overvalued in 2026?

Based on GuruFocus' analysis, Kerala Ayurveda stock appears to be undervalued. The current stock price of ₹178.90 is trading 43.9% below its estimated GF Value™ of ₹318.84. GuruFocus considers Kerala Ayurveda to be Possible Value Trap.

Key valuation signals for BOM:530163:

  • Forward Dividend Yield %: 0.00%
  • GF Value™: ₹318.84 vs. price of ₹178.90 (43.9% below fair value)
  • GF Score™: 47/100 with 4 warning signs

No single metric tells the full story. See the BOM:530163 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Kerala Ayurveda Business Description

Address XV/551, Athani Post, Nedumbassery, Ernakulam District, Ernakulam, KL, IND, 683585
Kerala Ayurveda Ltd is engaged in producing and selling ayurvedic products and providing healthcare services. The company offers ayurvedic medicine products for diabetes and heart health, skin and hair care, kids' health, women's care, men's care, gastro care, respiratory and allergy, general healthcare, massage oils, renal care, and joint care. It provides services through wellness clinics, resorts, hospitals, and academies. The company has only one reportable business segment, i.e., Full-spectrum Ayurvedic wellness. It generates maximum revenue from the sale of products. Geographically, the company generates maximum revenue from its business in India and also has some exposure to other markets.
47GF Score

Get the complete analysis for BOM:530163

Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹178.90
Price
₹318.84
GF Value